News

Briakinumab is an investigational anti-IL-12/23 monoclonal antibody for the treatment of psoriasis. In a filing with the Securities and Exchange Commission, the company said following feedback from regulatory

The premium DURAFLEX BX range now includes the new 10 mm, 15 mm and 20 mm suction cup sizes (models BX10P, BX15P and BX20P). Piab said the new

Health Canada has given Osiris 90 days to answer certain questions raised during the review. Osiris president and CEO Randal Mills said they intend to work with Health

The results revealed that bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease. Patients with melanoma that had

According to Genmed Holding, governmental pressure and new insurance policies, rather than the higher priced brand named pharmaceuticals, have increased the demand by general practitioners, specialists, and hospitals

Astellas Pharma Europe registered and launched luteinizing hormone-releasing hormone (LHRH) agonist Eligard in majority of European countries. Under the terms of the new agreement, the commercialization of Eligard

Oxford Outcomes provides specialist services in the areas of patient reported outcomes (PRO), health economics, epidemiology and translation and linguistic validation. Elizabeth Thiele, former ICON executive vice president

Through the new business unit, Callidus extends its footprint to provide sales lifecycle management solutions in the pharmaceutical and life sciences industry. The solutions are expected to optimize

Peramivir is an intravenously administered investigational anti-viral agent, which delivers high plasma concentrations to the sites of infection. The open-label, randomised, safety and virology Phase III study evaluated